Hector Esquer
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 21, 2025
Breast cancer cell coculture induces normal lung fibroblast transition to CAFs, promoting tumor cell dormancy and therapy resistance.Marika L Klosowski, Kathryn E Cronise, Eric P Palmer
|Mar 12, 2025
Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer.Hector Esquer, Qiong Zhou, Daniel V LaBarbera
|Dec 17, 2024
CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models.Rita Sala, Hector Esquer, Timothy Kellett
|Aug 29, 2024
CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.Rita Sala, Hector Esquer, Timothy Kellett
|Sep 23, 2022
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.Sébastien Rinaldetti, Qiong Zhou, Joshua M Abbott
Pageof 1
Frequent Collaborators
2 joint publications
Paul Awolade
2 joint publications
Daniel V LaBarbera
2 joint publications
Qiong Zhou
1 joint publications
Sébastien Rinaldetti
1 joint publications
Joshua M Abbott
1 joint publications
Florus C de Jong
1 joint publications
Sophia Clune
1 joint publications
Laura A Pike
1 joint publications
Marika L Klosowski
1 joint publications
Kelsie Sparks
